Evidence map›Paper›PMID 30241463›Full record

ArticleBMC bioinformatics2018

Overlapping group screening for detection of gene-gene interactions: application to gene expression profiles with survival trait.

Jie-Huei Wang, Yi-Hau Chen

Abstract read
In one paragraph

Article in BMC bioinformatics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jie-Huei WangInstitute of Statistical Science, Academia Sinica, Nankang, Taipei, Taiwan.
Yi-Hau ChenInstitute of Statistical Science, Academia Sinica, Nankang, Taipei, Taiwan. yhchen@stat.sinica.edu.tw.ORCID http://orcid.org/0000-0003-4038-9439

Funding

Ministry of Science and Technology, Taiwan MOST 104-2118-M-001-006-MY3
6 · The paper itself

Abstract

backgroundThe development of a disease is a complex process that may result from joint effects of multiple genes. In this article, we propose the overlapping group screening (OGS) approach to determining active genes and gene-gene interactions incorporating prior pathway information. The OGS method is developed to overcome the challenges in genome-wide data analysis that the number of the genes and gene-gene interactions is far greater than the sample size, and the pathways generally overlap with one another. The OGS method is further proposed for patients' survival prediction based on gene expression data.

resultsSimulation studies demonstrate that the performance of the OGS approach in identifying the true main and interaction effects is good and the survival prediction accuracy of OGS with the Lasso penalty is better than the ordinary Lasso method. In real data analysis, we identify several significant genes and/or epistasis interactions that are associated with clinical survival outcomes of diffuse large B-cell lymphoma (DLBCL) and non-small-cell lung cancer (NSCLC) by utilizing prior pathway information from the KEGG pathway and the GO biological process databases, respectively.

conclusionsThe OGS approach is useful for selecting important genes and epistasis interactions in the ultra-high dimensional feature space. The prediction ability of OGS with the Lasso penalty is better than existing methods. The OGS approach is generally applicable to various types of outcome data (quantitative, qualitative, censored event time data) and regression models (e.g. linear, logistic, and Cox's regression models).

Indexed as

Epistasis, GeneticGenetic LociTranscriptomeAlgorithmsCarcinoma, Non-Small-Cell LungComputer SimulationDatabases, FactualGene Expression ProfilingHumansLung NeoplasmsLymphoma, Large B-Cell, DiffusePredictive Value of TestsSurvival RateGene-gene interactionLassoOverlapping groupSurvival prediction

Identifiers

PMID30241463
PMCPMC6150983

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.